GlassScriptPhysician profile
Kevin Mcclain Cottingham
NPI 1043279797
$6,397.75
in general payments reported to CMS, 2019-2025
43 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,207 · 2020: $196 · 2021: $755 · 2022: $589 · 2023: $2,010 · 2024: $343 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451 · Travel and Lodging: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.72 |
| Travel and Lodging | $1,199.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,734.19 | 2019-2025 | Phasix Mesh |
| Endogastric Solutions, INC | $429.14 | 2019-2024 | Esophyx |
| Boston Scientific Corporation | $403.10 | 2019 | |
| Reshape Lifesciences INC. | $354.04 | 2019 | |
| Intuitive Surgical, INC. | $280.30 | 2019-2024 | |
| Medical Device Business Services, INC. | $264.82 | 2019 | |
| Intra-Sana Laboratories | $222.44 | 2022-2024 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Sunovion Pharmaceuticals INC. | $179.91 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $149.34 | 2019-2021 | |
| Kci USA, INC. | $143.08 | 2019 | |
| Integra Lifesciences Corporation | $135.44 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $92.61 | 2023-2024 | Nuzyra |
| Redhill Biopharma INC. | $76.42 | 2021-2022 | |
| Kerecis Limited | $73.63 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Melinta Therapeutics, LLC | $70.48 | 2019 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $67.37 | 2025 | Esophyx |
| Organogenesis INC. | $58.07 | 2019 | |
| Mylan Specialty L.P. | $57.76 | 2021 | |
| Astellas Pharma US INC | $51.17 | 2019 | |
| Ethicon US, LLC | $49.48 | 2019-2025 | Echelon; Endopath, Echelon Flex |
| Braintree Laboratories, INC. | $37.61 | 2024 | Sutab, Suflave |
| Convatec INC. | $36.45 | 2019-2022 | |
| Allergan, INC. | $36.42 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.93 | 2021 | |
| Mallinckrodt Hospital Products INC. | $28.60 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $27.47 | 2024 | Exparel |
| Medtronic, INC. | $25.08 | 2024 | Signia |
| Solventum Corporation | $24.89 | 2025 | Activ.A.C., Promogran Prisma, V.A.C. Veraflo |
| Regeneron Healthcare Solutions, INC. | $24.75 | 2022 | |
| Covidien LP | $21.99 | 2020 | |
| Glaxosmithkline, LLC. | $18.85 | 2020 | |
| Avanos Medical | $18.14 | 2024 | On-Q* Pump and Accessories |
| Tela Bio, INC. | $17.80 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.34 | 2021 | |
| Grifols USA, LLC | $17.10 | 2020 | |
| Pulmonx Corporation | $17.08 | 2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Lucid Diagnostics INC. | $16.64 | 2024 | |
| Lilly USA, LLC | $16.49 | 2025 | Mounjaro, Zepbound |
| Conmed Corporation | $16.13 | 2019 | |
| Currax Pharmaceuticals LLC | $15.89 | 2019 | |
| Baxter Healthcare | $15.34 | 2021 | |
| Smith+Nephew, INC. | $14.34 | 2024 | Renasys Go V2 Home |
| Harmony Biosciences LLC | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Cottingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.